Eastwood Bio-Medical Canada 

C$0.65
3
+C$0+0% 今天

统计数据

当日最高
0.65
当日最低
0.65
52周最高
1.15
52周最低
0.28
成交量
1,000
平均成交量
2,149
市值
52.35M
市盈率
-
股息收益率
-
股息
-

收益

29Jun预期
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q2 2021
Q1 2022
Q1 2022
-0
-0
-0
-0
预期每股收益
N/A
实际每股收益
-0.0003

人们还关注

此列表基于关注EBM.V的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. operates as a subsidiary of Eastwood Bio-Medical Research Inc.
Show more...
首席执行官
Dr. Youngsoo Kim
国家
CA
ISIN
CA27783W1059

上市公司